Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1872-2148
  • E-ISSN: 2212-3334

Abstract

Thyroid dysfunction and psychiatric disorders share a bidirectional relation. Thyroid hormones have been found to affect the central nervous system both structurally and functionally. Conventional antidepressant drug therapy is characterized by a delayed and at times suboptimal response. Various strategies have been devised in order to circumvent this limitation. L- Thyroxine has been used as both acceleration therapy and augmentation therapy as adjuvant therapy with antidepressants. The hormone has also been used as monotherapy, both in prevention and management of depression. The potential use of thyroid hormone as an adjunct therapy in management of euthyroid depression and relevant patents has been discussed.

Loading

Article metrics loading...

/content/journals/emi/10.2174/1872214807666131229130540
2014-01-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/emi/10.2174/1872214807666131229130540
Loading

  • Article Type:
    Research Article
Keyword(s): Antidepressant; depression; endocrinology; psychiatry; thyroid; thyroxine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test